Loading…
Loading grant details…
| Funder | Vinnova |
|---|---|
| Recipient Organization | Celluminova Ab |
| Country | Sweden |
| Start Date | Jan 01, 2024 |
| End Date | Mar 31, 2024 |
| Duration | 90 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swedish Research Council |
| Grant ID | 2023-04013_Vinnova |
Purpose and goal:
The MedTech4Health project has allowed Celluminova to acquire competences and tools needed for successful customer interactions for our in vitro diagnostic product, GlioStem-B. We will continue to build on this competence as the company grows with the aim that our product shall provide a much needed tool for neurosurgeons and, with time, benefit patients with malignant glioma.
Expected results and effects: ** Denna text är maskinöversatt **
The MedTech4Health project has led to increased clinical competence of Celluminova´s staff and thus increased opportunities to initiate clinical collaborations and set up well-designed clinical studies that benefit both Celluminova, surgeons and, most importantly, the patients. Approach and implementation:
** Denna text är maskinöversatt **
The project has been carried out together with a consultant and has taken place through training, discussions and own work. Celluminova is very satisfied with both the project and the collaboration.
Celluminova Ab
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant